-
Scandic Trust Group strengthens sales network with First Idea Consultant
-
US facing travel chaos as flights cut due to govt shutdown
-
Liverpool and Man City renew rivalry as they try to narrow Arsenal gap
-
UK's Andrew asked to testify over Epstein as he formally loses titles
-
Local hero: 'DC sandwich guy' found not guilty of assaulting officer with sub
-
Dead famous: Paris puts heritage graves up for grabs
-
UK grandmother on Indonesia death row flies home
-
Former NFL star Brown extradited from Dubai to face trial in shooting - police
-
Chile presidential hopeful vows to expel 'criminal' migrants to El Salvador
-
Trump event paused in Oval Office when guest faints
-
NFL Colts add Sauce to recipe while Patriots confront Baker
-
Home owned by Miami Heat coach Spoelstra damaged by fire
-
Tesla shareholders approve Musk's $1 trillion pay package
-
World leaders launch fund to save forests, get first $5 bn
-
Villa edge Maccabi Tel Aviv in fraught Europa League match
-
Protests as Villa beat Maccabi Tel Aviv under tight security
-
US Supreme Court backs Trump admin's passport gender policy
-
Japan boss Jones backs Farrell to revive Ireland's fortunes
-
MLB Padres name former reliever Stammen new manager
-
'Grand Theft Auto VI' video game delayed again until Nov. 2026
-
Martino returns as head coach of MLS Atlanta United
-
Hamilton dismisses Ferrari exit claims
-
Musetti keeps ATP Finals hopes alive, joins Djokovic in Athens semis
-
England boss Borthwick wants 'brilliant' Marcus Smith to shine against Fiji
-
Piastri says he is confident he can recover and win drivers' title
-
Verstappen admits he may need a bit of 'luck' to haul in rivals in title race
-
Kazakhstan to join Abraham Accords as Trump pushes Mideast peace
-
'Moral failure': Leaders seek to rally world at Amazon climate talks
-
UN Security Council votes to lift sanctions on Syrian president
-
Democratic giant, trailblazer and Trump foe Nancy Pelosi to retire
-
World leaders ditch ties at sweaty climate summit
-
Dallas Cowboys' Marshawn Kneeland dies at 24
-
Rally outside Rockstar against GTA studio's 'union busting'
-
McLaren boss says would rather lose title than issue team orders
-
Sabalenka, top WTA stars urge Slams to revive 'stalled' negotiations
-
5 killed in Afghan-Pakistan border fire despite peace talks: official
-
Trump unveils deals to lower costs of some weight-loss drugs
-
Controversial Canadian ostrich cull order will go ahead
-
Mexico's Sheinbaum to boost reporting of sexual abuse after being groped
-
Zuckerbergs put AI at heart of pledge to cure diseases
-
Crypto giant Coinbase fined in Ireland for rule breaches
-
Lawson relieved as he reveals FIA support following Mexican near-miss
-
US set for travel chaos as flights cut due to govt shutdown
-
Sabalenka and Pegula book their spots in WTA Finals last four
-
'Our brother-in-law': Arab world embraces New York's new mayor
-
France boss Deschamps would prefer to 'avoid playing' on Paris attacks anniversary
-
Pegula sweeps past Paolini to reach WTA Finals last four
-
Bolivian ex-president Anez leaves prison after sentence annuled
-
Stocks slide as investors weigh data, interest rate cuts
-
UN says 2025 to be among top three warmest years on record
US greenlights pig kidney transplant trials
Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their gene-edited pig kidneys for human transplants.
United Therapeutics along with another company, eGenesis, have been working since 2021 on experiments implanting pig kidneys into humans: initially brain-dead patients and more recently living recipients.
Advocates hope the approach will help address the severe organ shortage. More than 100,000 people in the United States are awaiting transplants, including over 90,000 in need of kidneys.
United Therapeutics's approval, announced Monday, allows the company to advance its technology toward a licensed product if the trial succeeds.
The study authorization was hailed as a "significant step forward in our relentless mission to expand the availability of transplantable organs," by Leigh Peterson, the company's executive vice president.
The trial will initially enroll six patients with end-stage renal disease before expanding to as many as 50, United Therapeutics said in a statement. The first transplant is expected in mid-2025.
Meanwhile, rival eGenesis said it had received FDA approval in December for a separate three-patient kidney study.
"The study will evaluate patients with kidney failure who are listed for a transplant but who face a low probability of receiving a deceased donor offer within a five-year timeframe," the company said.
Xenotransplantation -- transplanting organs from one species to another -- has been a tantalizing yet elusive goal for science.
Early experiments in primates faltered, but advances in gene editing and immune system management have brought the field closer to reality.
Pigs have emerged as ideal donors: they grow quickly, produce large litters, and are already part of the human food supply.
United Therapeutics said trial patients would be monitored for life, assessing survival rates, kidney function, and the risk of zoonotic infections -- diseases that jump from animals to humans.
Currently, there is only one living human recipient of a pig organ: Towana Looney, a 53-year-old from Alabama who received a United Therapeutics kidney on November 25, 2024.
She is also the longest-surviving recipient, having lived with a pig kidney for 71 days as of Tuesday. David Bennett of Maryland received a pig heart in 2022 and survived 60 days.
M.A.Colin--AMWN